13F Insight
DOSSIER · 13F Holders · Q2 2026
CNSP

CNS Pharmaceuticals Inc

11 institutions still hold CNS Pharmaceuticals Inc as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 18978H508·11 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$801K
visible holders
Holders
11
filers reporting
Concentration
41.76%
ADAR1 Capital Management, LLC #1
top holder share
AI Holders Summary · Q2 2026

11 institutions reported CNSP in Q2 2026. ADAR1 Capital Management, LLC leads at 41.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
ADAR1 Capital Management, LLC
CIK 0001940272
$335K70K0.02%Q2 202602
Stonepine Capital Management, LLC
CIK 0001440771
$199K42K0.11%Q2 202603
Ikarian Capital, LLC
CIK 0001778253
$110K46K0.01%Q1 202604
BOOTHBAY FUND MANAGEMENT, LLC
CIK 0001549230
$65K14K0.00%Q2 202605
VANGUARD FIDUCIARY TRUST CO
CIK 0000933478· Index
$49K10K0.00%Q2 202606
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$33K7K0.00%Q2 202607
UBS Group AG
CIK 0001610520
$7K1K0.00%Q2 202608
Tower Research Capital LLC (TRC)
CIK 0001533421
$4K7990.00%Q2 202609
BARCLAYS PLC
CIK 0000312069
$91190.00%Q2 202610
BARRETT & COMPANY, INC.
CIK 0000887602
$3880.00%Q2 202611
DANSKE BANK A/S
CIK 0000800177
$510.00%Q2 2026
Insiders at CNS Pharmaceuticals Inc
Levin Rami →Fisher Michal →Charles Faith L. →Cockroft Bettina M. →Mahery Amy →Gumulka Jerzy →Downs Christopher →Keyes Jeffry R. →